VCYT vs. IBRX

Last updated Jun 3, 2026

VCYT (Veracyte, Inc.) and IBRX (ImmunityBio, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 10 years, VCYT returned 24.60%/yr vs -0.67%/yr for IBRX. At a 0.36 correlation, their price movements are largely independent.

Performance

VCYT vs. IBRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Veracyte, Inc. (VCYT) and ImmunityBio, Inc. (IBRX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, VCYT achieves a 13.54% return, which is significantly lower than IBRX's 265.15% return. Over the past 10 years, VCYT has outperformed IBRX with an annualized return of 24.60%, while IBRX has yielded a comparatively lower -0.67% annualized return.

VCYT

• 1D: -0.79%
• 1M: 44.45%
• YTD: 13.54%
• 6M: 3.55%
• 1Y: 78.76%
• 3Y*: 21.39%
• 5Y*: 7.11%
• 10Y*: 24.60%

IBRX

• 1D: -0.14%
• 1M: 1.69%
• YTD: 265.15%
• 6M: 245.93%
• 1Y: 170.79%
• 3Y*: 37.68%
• 5Y*: -16.43%
• 10Y*: -0.67%

*Multi-year figures are annualized to reflect compound growth (CAGR)

VCYT vs. IBRX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
VCYT Veracyte, Inc.	13.54%	6.31%	43.95%	15.93%	-42.40%	-15.82%	75.29%	121.94%	92.65%	-15.63%
IBRX ImmunityBio, Inc.	265.15%	-22.66%	-49.00%	-0.99%	-16.61%	-54.39%	251.72%	226.72%	-74.16%	-21.50%

Correlation

The correlation between VCYT and IBRX is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.23
Correlation (3Y) Calculated over the trailing 3-year period	0.32
Correlation (5Y) Calculated over the trailing 5-year period	0.44
Correlation (10Y) Calculated over the trailing 10-year period	0.36
Correlation (All Time) Calculated using the full available price history since Jul 29, 2015	0.36

The correlation between VCYT and IBRX shifts across timeframes, from 0.23 (1 year) to 0.44 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap VCYT : $3.89B IBRX : $7.42B
EPS VCYT : $1.09 IBRX : -$0.89
PS Ratio VCYT : 7.11 IBRX : 49.38
Total Revenue (TTM) VCYT : $541.74M IBRX : $140.98M
Gross Profit (TTM) VCYT : $386.89M IBRX : $132.23M
EBITDA (TTM) VCYT : $99.47M IBRX : -$196.14M

Return for Risk

VCYT vs. IBRX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VCYT

VCYT Risk / Return Rank: 77
VCYT Sharpe Ratio Rank: 77
VCYT Sortino Ratio Rank: 82
VCYT Omega Ratio Rank: 77
VCYT Calmar Ratio Rank: 74
VCYT Martin Ratio Rank: 72

IBRX

IBRX Risk / Return Rank: 83
IBRX Sharpe Ratio Rank: 83
IBRX Sortino Ratio Rank: 85
IBRX Omega Ratio Rank: 82
IBRX Calmar Ratio Rank: 87
IBRX Martin Ratio Rank: 78

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VCYT vs. IBRX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Veracyte, Inc. (VCYT) and ImmunityBio, Inc. (IBRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	VCYT	IBRX	Difference
Sharpe ratio Return per unit of total volatility	1.32	1.63	-0.31
Sortino ratio Return per unit of downside risk	2.53	2.76	-0.23
Omega ratio Gain probability vs. loss probability	1.29	1.33	-0.04
Calmar ratio Return relative to maximum drawdown	2.03	4.05	-2.02
Martin ratio Return relative to average drawdown	4.42	6.02	-1.60
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

VCYT vs. IBRX - Sharpe Ratio Comparison

The current VCYT Sharpe Ratio is 1.32, which is comparable to the IBRX Sharpe Ratio of 1.63. The chart below compares the historical Sharpe Ratios of VCYT and IBRX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	VCYT	IBRX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.32	1.63	-0.31
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.11	-0.15	+0.26
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.40	-0.01	+0.40
Sharpe Ratio (All Time) Calculated using the full available price history	0.18	-0.12	+0.30

Drawdowns

VCYT vs. IBRX - Drawdown Comparison

The maximum VCYT drawdown since its inception was -81.19%, smaller than the maximum IBRX drawdown of -97.14%. Use the drawdown chart below to compare losses from any high point for VCYT and IBRX.

Drawdown Indicators

	VCYT	IBRX	Difference
Max Drawdown Largest peak-to-trough decline	-81.19%	-97.14%	+15.95%
Max Drawdown (1Y) Largest decline over 1 year	-39.23%	-42.44%	+3.21%
Max Drawdown (3Y) Largest decline over 3 years	-50.09%	-79.34%	+29.25%
Max Drawdown (5Y) Largest decline over 5 years	-71.54%	-92.83%	+21.29%
Max Drawdown (10Y) Largest decline over 10 years	-81.19%	-97.03%	+15.84%
Current Drawdown Current decline from peak	-41.26%	-82.89%	+41.63%
Average Drawdown Average peak-to-trough decline	-48.36%	-83.91%	+35.55%
Ulcer Index Depth and duration of drawdowns from previous peaks	18.02%	28.54%	-10.52%

Volatility

VCYT vs. IBRX - Volatility Comparison

Veracyte, Inc. (VCYT) has a higher volatility of 26.45% compared to ImmunityBio, Inc. (IBRX) at 22.80%. This indicates that VCYT's price experiences larger fluctuations and is considered to be riskier than IBRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	VCYT	IBRX	Difference
Volatility (1M) Calculated over the trailing 1-month period	26.45%	22.80%	+3.65%
Volatility (6M) Calculated over the trailing 6-month period	39.28%	89.45%	-50.17%
Volatility (1Y) Calculated over the trailing 1-year period	59.88%	105.21%	-45.33%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	64.48%	113.45%	-48.97%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	62.00%	111.42%	-49.42%

Dividends

VCYT vs. IBRX - Dividend Comparison

Neither VCYT nor IBRX has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both VCYT and IBRX in my portfolio?

VCYT and IBRX have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, VCYT or IBRX?

VCYT has higher volatility (26.45%) compared to IBRX (22.80%). In terms of maximum drawdown, VCYT dropped -81.19% vs IBRX's -97.14%.

Which has better risk-adjusted returns?

IBRX currently has the higher Sharpe Ratio (1.63 vs 1.32), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.